Oxford Biomedica (OXB) RNS Announcements

Add to Alert list
Date Time Source Announcement
01 Dec 2025 07:00 AM
RNS
Total Voting Rights
03 Nov 2025 04:55 PM
RNS
Holding(s) in Company
03 Nov 2025 07:00 AM
RNS
Total Voting Rights
29 Oct 2025 01:59 PM
RNS
OXB honoured at 2025 CDMO Leadership Awards Europe
27 Oct 2025 07:00 AM
RNS
OXB to participate in investor conferences
20 Oct 2025 05:54 PM
RNS
Director/PDMR Shareholding
20 Oct 2025 05:13 PM
RNS
Director/PDMR Shareholding
20 Oct 2025 10:17 AM
RNS
Board Change
16 Oct 2025 07:00 AM
RNS
Director/PDMR Shareholding
07 Oct 2025 07:00 AM
RNS
Acquisition of US viral vector facility
01 Oct 2025 07:00 AM
RNS
Total Voting Rights
23 Sep 2025 07:00 AM
RNS
Interim Results for 6 months ended 30 June 2025
01 Sep 2025 07:00 AM
RNS
Total Voting Rights
22 Aug 2025 03:36 PM
RNS
PDMR Dealings
21 Aug 2025 10:24 AM
RNS
Holding(s) in Company
20 Aug 2025 07:00 AM
RNS
Admission of Shares and Total Voting Rights
15 Aug 2025 01:45 PM
RNS
PDMR Dealings
15 Aug 2025 07:05 AM
RNS
Results of Placing
14 Aug 2025 05:02 PM
RNS
Proposed Placing of New Ordinary Shares
01 Aug 2025 07:00 AM
RNS
OXB Secures New Loan Facility with Oaktree
01 Aug 2025 07:00 AM
RNS
Total Voting Rights
28 Jul 2025 07:00 AM
RNS
Half Year Trading Update
02 Jul 2025 07:00 AM
RNS
Director Declaration
01 Jul 2025 07:00 AM
RNS
Block listing Interim Review
01 Jul 2025 07:00 AM
RNS
Total Voting Rights
23 Jun 2025 07:00 AM
RNS
OXB completes acquisition of US subsidiary
17 Jun 2025 06:00 PM
RNS
Director/PDMR Shareholding
11 Jun 2025 06:02 PM
RNS
Result of Annual General Meeting
11 Jun 2025 07:02 AM
RNS
AGM Update
10 Jun 2025 10:49 AM
RNS
Holding(s) in Company
05 Jun 2025 07:00 AM
RNS
Block Listing Application
03 Jun 2025 07:00 AM
RNS
OXB Launches Advisory Board
02 Jun 2025 07:00 AM
RNS
Total Voting Rights
16 May 2025 05:52 PM
RNS
Grant of options
01 May 2025 07:00 AM
RNS
Total Voting Rights
30 Apr 2025 04:49 PM
RNS
Person Closely Associated Dealing
29 Apr 2025 06:14 PM
RNS
Holding(s) in Company
28 Apr 2025 01:00 PM
RNS
2025 Annual General Meeting notification
23 Apr 2025 05:45 PM
RNS
Holding(s) in Company
09 Apr 2025 07:00 AM
RNS
Preliminary results for the year ended 31 Dec 2024
04 Apr 2025 08:52 AM
RNS
Holding(s) in Company
01 Apr 2025 07:00 AM
RNS
OXB Total Voting Rights
27 Mar 2025 04:45 PM
RNS
Director Declaration
03 Mar 2025 09:00 AM
RNS
Total Voting Rights
26 Feb 2025 07:00 AM
RNS
OXB to present at Leerink Conference
20 Feb 2025 03:42 PM
RNS
Holding(s) in Company
20 Feb 2025 01:32 PM
RNS
OXB Lentiviral Vectors Used in Gene Therapy Trial
20 Feb 2025 01:13 PM
RNS
Standard form for notification of major holdings
17 Feb 2025 07:00 AM
RNS
Full Year Trading Update and Notice of Results
05 Feb 2025 07:00 AM
RNS
Appointment of New Joint Corporate Broker

Oxford Biomedica is a company that specialises in cell and gene therapy, and is a leader in the development of gene-based medicines. They work with pharmaceutical and biotechnology companies to develop and manufacture viral vectors, including lentivirus, adeno-associated virus, and adenoviral vectors.

Headquartered in Oxford, Oxford Biomedica has manufacturing facilities in Oxfordshire, UK, Lyon and Strasbourg, France, and near Boston, MA, US.

Oxford Biomedica share price listed in London under the ticker OXB at 2,570p.

UK 100

Latest directors dealings